2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

Giulia Letizia Mauro; Antonio Russo; Dalila Scaturro; Viviana Bazan; Antonio Galvano

2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

Giulia Letizia Mauro, Antonio Russo, Dalila Scaturro, Viviana Bazan, Antonio Galvano

Risultato della ricerca: Letter

Lingua originale	English
Numero di pagine	1
Rivista	Journal of Bone Oncology
Stato di pubblicazione	Published - 2020

All Science Journal Classification (ASJC) codes

Oncology

Accesso al documento

OA Link

Cita questo

Letizia Mauro, G., Russo, A., Scaturro, D., Bazan, V., & Galvano, A. (2020). 2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials. Journal of Bone Oncology.

@article{52f3b6c33a864f428f25e4c412fbf4ae,

title = "2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials",

author = "{Letizia Mauro}, Giulia and Antonio Russo and Dalila Scaturro and Viviana Bazan and Antonio Galvano",

year = "2020",

language = "English",

journal = "Journal of Bone Oncology",

issn = "2212-1374",

publisher = "Elsevier GmbH",

}

TY - JOUR

T1 - 2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

AU - Letizia Mauro, Giulia

AU - Russo, Antonio

AU - Scaturro, Dalila

AU - Bazan, Viviana

AU - Galvano, Antonio

PY - 2020

Y1 - 2020

UR - http://hdl.handle.net/10447/423059

M3 - Letter

JO - Journal of Bone Oncology

JF - Journal of Bone Oncology

SN - 2212-1374

ER -